All serious fungal infections need appropriate antifungal therapy for successful patient
outcome. Only a few classes of antifungal drugs are available, so the emergence of …

The genus Candida includes about 200 different species, but only a few species are human
opportunistic pathogens and cause infections when the host becomes debilitated or …

This analysis describes the epidemiology and outcomes of invasive candidiasis caused by
non-albicans species of Candida in patients enrolled in the Prospective Antifungal Therapy …

The human body is home to a complex and diverse microbial ecosystem that plays a central
role in host health. This includes a diversity of fungal species that is collectively referred to …

Mycoses summarized in the hyalohyphomycosis group are heterogeneous, defined by the
presence of hyaline (non‐dematiaceous) hyphae. The number of organisms implicated in …

The mortality associated with invasive fungal infections remains high with that involving rare
yeast pathogens other than C andida being no exception. This is in part due to the severe …

A growing population of immunosuppressed patients has resulted in increasingly frequent
diagnoses of invasive fungal infections, including those caused by unusual yeasts. The …

Invasive candidiasis (IC) is a leading cause of mycosis-associated mortality in the United
States. We examined data from the National Center for Health Statistics and reviewed recent …

The incidence of invasive mycoses is increasing, especially among patients who are
immunocompromised or hospitalized with serious underlying diseases. Such infections may …

Fluconazole in vitro susceptibility test results for 256,882 isolates of Candida spp. were
collected from 142 sites in 41 countries from June 1997 to December 2007. Data were …